Nouveau Life Pharmaceuticals, Inc. (NOUV)
- Previous Close
0.0002 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0002 - 0.0002 - 52 Week Range
0.0001 - 0.0003 - Volume
135,555 - Avg. Volume
3,137,175 - Market Cap (intraday)
1.332M - Beta (5Y Monthly) -0.12
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in the development of nutraceuticals products. It provides natural alternatives and prescription drugs. The company was formerly known as Hybrid Fuels, Inc. and changed its name to Nouveau Life Pharmaceuticals, Inc. in May 2012. Nouveau Life Pharmaceuticals, Inc. was incorporated in 1998 and is based in Ft. Lauderdale, Florida. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of EMG Marketing Solutions, Inc.
--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: NOUV
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NOUV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NOUV
Valuation Measures
Market Cap
1.33M
Enterprise Value
1.33M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-5.65
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-19.83%
Return on Equity (ttm)
-219.52%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-503.31k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
1.1k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
101.54k
Company Insights: NOUV
NOUV does not have Company Insights